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Prognosis for surgically treated gastric cancer patients is poorer for
women than men in all patients under age 50
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Department ofSurgery II, Faculty ofMedicine, Kvushu University, Fukuoka, Japan.
Summan From 1965 to 1983. 1031 patients (689 men and 342 women) with advanced gastric cancer
underwent gastric resection in our department. A retrospective study was done with special reference to the sex
of the patients. The age. tumour size and location. Borrmann type. and histology were considered as the
sex-related associations. The survival rate of women under age 50 years was lower than that of men. with a
significant difference (P<0.01). and the 10-year survival rate was 39.2% for the men and 29.3% for the
women. A multivariate analysis showed that the operative curability (relative n'sk: 2.11). lymph node
metastasis (relative n'sk: 1.37). depth of invasion (relative risk: 1.30) and tumour size (relative risk: 1.05). all
significant prognostic factors. differed between the men and women under age 50 years. and the survival rate
for women was lower. Thus. early detection of gastric cancer is crucial to improve the survival of women
under age 50 vears Postoperative chemotherapy may be considered for those with an advanced gastric cancer.
The emphasis on early diagnosis, operative techniques of
extensive lymph node dissection (Kodama et al.. 1981; Boku
et al.. 1989) and postoperative chemotherapy has led to a
longer survival time for patients with gastric cancer (The
Gastrointestinal Tumor Study Group. 1982: Maehara et al..
1990a). Nevertheless, for a large number of patients with
advanced gastric cancer. palliative surgery remains the only
choice of treatment and the 5-year survival rate for a stage
IV lesion remains around 10% (Korenaga et al.. 1988).
Hepatic metastasis. peritoneal dissemination, widespread
nodal involvement, depth of invasion and other factors
influence the prognosis. but the sex is apparently not a
prognostic factor (Baba et al.. 1989: Korenaga et al., 1989:
Shiu et al.. 1989). The male to female ratio in patients with
gastric cancer is 2:1. while the number of females affected
increases in cases of diffuse type carcinomas, and in young
patients (Lauren. 1965; Bloss et al.. 1980: Matley et al.. 1988:
Mitsudomi et al.. 1989a). Sex hormones play a role in
cancers originating in the prostate, breast, or uterine
endometrium and also in cancers of the oesophagus and lung
(Sugimachi et al.. 1987; Mitsudomi et al.. 1989b). In this
context, we analysed various clinical characteristics in
patients with gastric cancer following gastric resection, with
special reference to the sex of patients.
Patients and methods
Patients
This studv was based on a retrospective analysis of 1031
patients with advanced gastric adenocarcinoma and who
were treated in the Department of Surgery II, Ky-ushu
University Hospital. Fukuoka, Japan. between 1965 and
1983. Pathological diagnosis and classifications were
evaluated according to the General Rules for the Gastric
Cancer Study in Surgery and Pathology in Japan (Japanese
Research Society for Gastric Cancer. 1981).
Statistical analisis
The BMDP Statistical Package program for the IBM 4381
mainframe computer was used for all analyses (Dixon. 1985).
The BMDP P4F and P3S programs were used for the
test and the Mann-Whitney test was used to compare data
on the sexes. The BMDP PIL program was used for the
Kaplan-Meier method to analyse surVival rates and the
generalised Wilcoxon test to test for equality of survival
curves between the sexes. The BMDP P2L program was used
for multivariate adjustments for all covariates, simul-
taneously. using the Cox regression analysis (Cox. 1972). The
level of significance was P<0.05.
Results
Patients
Of the 1031 patients. 25.40o were under age 50 years. 60.6%
were in the 51-70 age group and 14.0% were over age 71
years. as shown in Table I. Gastric cancer occurred more
frequently in men, a ratio of 2:1 (male female), and in those
under age 50 years. the ratio was near 1:1.
Clinicopathologicalfactors
Table II shows clinicopathological data on all the patients
who underwent gastric resection. There were statistical
differences in the age. tumour size, location of tumour, Borr-
mann type and histology between the sexes. We also analysed
the clinicopathological factors in three groups. In group 1
patients under age 50 years. statistical differences were noted
in tumour size, Borrmann type. histology, depth of invasion.
lymph node metastasis and operative curability. In particular.
the rate of lymph node metastasis (82.80%o) and serosal
invasion (83.6%) was prominent and a non-curative resection
was done (50.8%) (Table III). The cinicopathological factors
related to palliative resection are shown in Table IV. The
incidence of infiltration at the oral margin: ow( + ) was
higher in women under 50 years of age than in men. In the
group 2 patients. aged 51-70 years, differences were noted
only in tumour size, Borrmann type and histology and in
group 3 patients aged over 71 years, there were no apparent
differences in clinicopathological factors.
Table I Patients classified by sex and age
.4ge Men Women Total U F
f; 50 140(20.3° o) 122(35.7°0) 262(25.40o0) 1.15
51"-70 450(65.30/%) 175(51.1°%) 625(60.60 o) 2.57
71 <, 99(14.4%o) 45(13.2%) 144(14.0O.) 2.13
Total 689(100%) 342(100%) 1031(1000.) 2.01
M F: male female
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of clinicopathological factors between men
and women
.Men Women
Variable (n =689 (n = 342a P value
Age 58.9± 11.4a 55.5 13.9 P<0.01
Tumour maximal 7.8 3.6 8.8 4.2 P<0.01
diameter (cm)
Location of
tumour
Upper (C) 207(30.00o) 86(25.100) P<0.01
Middle (M) 176(25.50o) 118(34.5° o)
Lower (A) 306(44.5P.) 138(40.4°o)
Borrmann
Type 1 16(2.3.o) 601.8.o) P<0.01
Type 2 193(28.0°o) 86(25.1 ° o)
Type 3 301(43.70o) 127(37.1%°o)
Type 4 91(13.2°0o) 85(24.9%)
Type 5 88(12.8°%) 38(l1.1°o)
Histology
Differentiated 347(50.40o) 110(32.200) P<0.01
Undifferentiated 342(49.6°o) 232(67.80o)
Prognostic serosal
invasion (ps)b
Negative 193(28.00°o) 77(22.500) NS
Positive 496(72.00o) 265(77.50o)
Histological lymph
node metastasis
Negative 159(23.1% o) 85(24.90.o) NS
Positive 530(76.9go) 257(75.1°o)
Peritoneal
dissemination
Negative 600(87.1 0o) 282(82.50o) NS
Positive 89(12.90/0) 60(17.50D)
Liver metastasis
Negative 633(91.9%o) 324(94.70o) NS
Positive 56(8.10%) 18(15.3°o)
Operative procedure
Partial 390(56.60o) 178(52.00o) NS
Total 299(43.40o) 16(48.00o)
Curabilitv
Curative 403(58.50,o) 186(54.400) NS
Non-curative 286(41.50o) 156(45.60o)
'mean ± standard deviation. bPrognostic serosal invasion (ps)-
negative contains mucosa. submucosa. muscularis propria and
subserosa (expansive, intermediate). and ps positive contains
subserosa (infiltrative). serosa and serosa infiltrating the
neighbouring tissue. NS. no significant difference.
To determine which of the many covariates had the most
prognostic significance with regard to survival time, a mul-
tivariate analysis was made (Maehara et al., 1991b,c). Liver
metastasis, operative curability, peritoneal dissemination.
operative procedure, lymph node metastasis, depth of
invasion and tumour size proved to be independent risk
covariates in all patients even those under age 50 years, after
gastric resection (Table V).
Survival rates
Postoperative survival curves for all patients are shown in
Figure 1. At the time of analysis, the median follow-up time
for the 226 patients was 13.5 years. The generalised Wilcoxon
test of the two survival patterns revealed no significance. The
10-year survival rate was 34.5% for men and 32.6% for
women. In patients under 50 years of age (group 1), the
survival rates for the women were lower than those for men,
with a statistical difference (P<0.01), as shown in Figure 2.
The 10-year survival rate was 39.2% for the men and 29.3%
for the women. In group 2 aged 51-70 years and group 3
aged over 71 years. there were no differences in survival rates
between the sexes.
Eiscusi
Several clinicopathological factors are involved in determin-
ing the prognosis for patients with a gastric cancer (Baba et
Table III Comparison of clinicopathological factors between men
and women under 50 years of age
.Men Women
lariable (n = 140 (n = 122) P value
Age 41.7±7. a 40.2±8.1 NS
Tumour maximal 7.7 4.la 9.2 ± 4.3 P<0.01
diameter (cm)
Location of tumour
Upper (C) 42(30.00o) 33(27.00o) NS
Middle (M) 43(30.70o ) 49(40.2 o.)
Lower (A) 55(39.30 o) 40(32.80o)
Borrmann
Type I O0(,o) 1( 0.80.) P<0.05
Type 2 34(24.3g.) 24(19.70o)
Type 3 57(40.7°o) 50(41.00.)
Type 4 23(16.40 o) 35(28.700)
Type 5 26(18.60o) 12(9.80o)
Histolog;
Differentiated 52(37.100) 25(20.50 o) P<0.0l
Undifferentiated 88(62.90o) 97(79.5° o)
Prognostic serosal
invasion (ps)b
Negative 4+R31.40 o) 2006.40 o) P<0.01I
Positive 96(68.60o) 102(83.6°o)
Histological l1mph
node metastasis
Negative 40(28.60o) 21(17.20o) P<0.05
Positive 100(71.40°o) 101(82.800)
Pen'toneal
dissemination
Negative 118(84.3°o) 9+77.00o) NS
Positive 22(15.70o) 28(23.00o)
Liver metastasis
Negative 133(95.0°o) 119(97.50o) NS
Positive 7(5.0°o) 3(2.50.)
Operative procedure
Partial 80(57.10 °) 58(47.50o) NS
Total 60(42.90o) 64(52.50o )
Curability
Curative 92(65.700o) 60(49.20'o) P<0.01
Non-curative 48(34.30o) 62(50.80.o)
aMean ± standard deViation. tThe definition of ps is given in Table
I. NS. no significant difference.
Table In Factors involved in non-curative resection in men and
women under 50 vears of age
Mfen u omen
Variable (n = 48 (n = 62v
Serosal invasion 1(2.10°) 4(6.5°iO)
Lymph node metastasis 10(20.80°o0) 10(16.10°o )
ow ( + ) 5(10.4°o) 11(17.70°o)
a ( + ) 4(8.30o) 6(9.7'.)
ow ( + ) and aw ( +) 2(4.2°%) 1 (1.6%')
Penrtoneal dissemination 19(39.60o) 27(43.60o)
Liver metastasis 4(8.30°o) 2(3.2°o.)
Penrtoneal dissemination 3(6.300o) 1(1.60°00
and liver metastasis
ow (+) = cancer infiltration at the oral margin; aw (+) =
cancer infiltration at the anal margin.
al.. 1989; Korenaga et al., 1989; Shiu et al., 1989; Maehara et
al.. 1991a,c). The sex of the patients was not a significant
factor influencing the prognosis; however, clinicopathological
factors of gastric cancer between the sexes do differ. The
number of women affected was half that of men, but in-
creased 1:1 in the young generation. The undifferentiated
type (Sugano et al., 1982) which shows a diffusely infiltrative
growth pattern was prominent in women. In young patients
and in one case of diffuse types of tumours, the rate of
occurrence of gastric cancer increases in the female sex and a
high frequency of pregnancy in young women with gastric
cancer has been noted (Lauren, 1965; Bloss et al.. 1980;
Matley et al., 1988; Mitsudomi et al., 1989a). However, as
pregnancy most often occurs in this age group, an associa-
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Table V Cox regression analysis of data on patients under 50 years
of age
Covariate P value Relative risk
Liver metastasis <0.01 4.53
Curability <0.01 2.11
Peritoneal dissemination <0.01 1.78
Operative procedure <0.01 1.46
Lvmph node metastasis <0.01 1.37
Depth of invasion <0.01 1.30
Tumour maximal diameter <0.01 1.05
100
Men (n = 689)
Women (n = 342)
*50
0 5 10 15
Time after operation (years)
689 202 120 65
342 101 58 29
Figre I Sun-ival curses for all patients of both sexes. Numbers
of patients elieible for analysis at each point are shown.
tion could be fortuitous (Matley et al.. 1988). The presence of
oestrogen receptors and intracytoplasmic oestradiol in a pro-
portion of patients of all ages fails to explain the
preponderance of women among young patients (Nishi et al..
1987).
Armstrong and Dent (1986) reported that the survival rate
of women with gastric cancer exceeds that of men. and
Stemmermann and Brown (1974) reported that women with
a diffuse gastric cancer had longer survival rates than did
men. On the other hand. a diffuse type of gastric cancer
which is relatively more frequent in women and young
patients. results in a shorter survival time than seen with
intestinal type or other types of histology (Lauren. 1965: Tso
et al.. 1987). In our patients under age 50 years. the
clinicopathological factors differed between the sexes. includ-
100
Men (n = 140)
Women (n = 122)
50
0 5 10 15
Time after operation (years)
140 58 43 30
122 30 23 15
Figure 2 Survival curves for men and women under 50 years of
age. Numbers of patients eligible for analysis at each point are
shown.
ing factors of tumour size. Borrmann type. histology. depth
of invasion. Iymph node metastasis and operative curability.
In particular. advanced cases were dominant in women and
most often a non-curative resection was done. Therefore. the
statistical lower survival rate for the women under age 50
years is expected to be influenced by operative curability.
lymph node metastasis. depth of invasion and tumour size.
all significant prognostic factors (Table IV). Clinical diag-
nosis mav be made late and the young age of the women is
the major deterrent to early diagnosis (Bloss et al.. 1980).
As tumour cells left behind at surgery may proliferate
rapidly in non-curatively resected cases (Schabel. 1975: Gun-
duz et al.. 1979). the potential to control the remaining
tumour foci is significantly reduced by postponing
chemotherapy to the later postoperative period (Tubiana &
Malaise. 1976: Douglass. 1985). We found that the
undifferentiated gastric cancer tissue is more sensitive to
anti-tumour drugs than is differentiated cancer tissue. in *-itro
(Maehara et al.. 1987) and the undifferentiated type is
dominant in women under age 50 years. Therefore. pos-
toperative chemotherapy. for example with the combination
of mitomycin C. fluorinated pyrimidine and the
immunomodulator PSK. should be initiated in a few days
and continued for 1 year in the postoperative period
(Maehara et al.. 1990a.b).
We thank M. Ohara for comments.
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